Cargando…
Improvement in Quality of Life with OnabotulinumtoxinA for Cervical Dystonia: POSTURe
INTRODUCTION: Symptoms of cervical dystonia (CD) can vary in severity and cause significant pain. OnabotulinumtoxinA is an approved treatment for CD. This study assessed health-related quality of life (HRQoL) in patients with CD who received multiple onabotulinumtoxinA treatments. METHODS: This pros...
Autores principales: | Petitclerc, Marc, Cloutier, Martin, Naud, Pierre, Langlois, Mélanie, Bhogal, Meetu, Davidovic, Goran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527835/ https://www.ncbi.nlm.nih.gov/pubmed/33342445 http://dx.doi.org/10.1017/cjn.2020.275 |
Ejemplares similares
-
Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia
por: Kilbane, Camilla, et al.
Publicado: (2012) -
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Jankovic, Joseph, et al.
Publicado: (2023) -
Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia
por: Misra, V. P., et al.
Publicado: (2020) -
Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia
por: Marsh, Wallace A, et al.
Publicado: (2014) -
The Effect of Low Dose OnabotulinumtoxinA on Cervical Dystonia in Hypermobile Ehlers-Danlos Syndrome
por: Wang, Tina J., et al.
Publicado: (2021)